1
TITLE: Measurable Residual Disease Assessment in Multiple Myeloma: How Deep Is Enough?
AUTHORS: Joana Caetano; Filipa Barahona; Paulo Lúcio; Cristina João;
PUBLISHED: 2022, SOURCE: Hemato, VOLUME: 3, ISSUE: 3
INDEXED IN: CrossRef: 2
IN MY: ORCID
2
TITLE: Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial
AUTHORS: Mateos, MV; Cavo, M; Blade, J; Dimopoulos, MA; Suzuki, K; Jakubowiak, A; Knop, S; Doyen, C; Lucio, P; Nagy, Z; Pour, L; Cook, M; Grosicki, S; Crepaldi, A; Liberati, AM; Campbell, P; Shelekhova, T; Yoon, SS; Iosava, G; Fujisaki, T; Garg, M; Krevvata, M; Chen, Y; Wang, JP; Kudva, A; Ukropec, J; Wroblewski, S; Qi, M; Kobos, R; San Miguel, J; ...More
PUBLISHED: 2020, SOURCE: LANCET, VOLUME: 395, ISSUE: 10218
INDEXED IN: WOS CrossRef: 303
IN MY: ORCID
3
TITLE: Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma
AUTHORS: Weisel, K; Dimopoulos, M; Moreau, P; Yagci, M; Larocca, A; Kanate, AS; Vural, F; Cascavilla, N; Basu, S; Johnson, P; Byeff, P; Hus, M; Rodr?guez Otero, P; Muelduer, E; Anttila, P; Hayden, PJ; Krauth, MT; Lucio, P; Ben Yehuda, D; Mendeleeva, L; Guo, SE; Yu, X; Grote, L; Biyukov, T; Dhanasiri, S; Richardson, P; ...More
PUBLISHED: 2020, SOURCE: LEUKEMIA & LYMPHOMA, VOLUME: 61, ISSUE: 8
INDEXED IN: Scopus WOS CrossRef: 11
IN MY: ORCID
4
TITLE: Multiple myeloma in elderly patientsa Portuguese multicentric real-life study  Full Text
AUTHORS: Joao, C; Bergantim, R ; Neves, M; Chacim, S; Afonso, C; Barradas, J; Bernardo, M; Coelho, H; Esteves, G; Fraga, C; Geraldes, C; Goncalves, C; Jorge, A; Macedo, A; Mendonca, T; Moreira, A; Roque, A; Sarmento, AB; Trigo, F; Vitoria, H; Esteves, S; Lucio, P; ...More
PUBLISHED: 2019, SOURCE: ANNALS OF HEMATOLOGY, VOLUME: 98, ISSUE: 7
INDEXED IN: Scopus WOS CrossRef: 6
IN MY: ORCID
5
TITLE: Chimeric antigen receptor T-cell therapy for multiple myeloma: a consensus statement from The European Myeloma Network
AUTHORS: Moreau, P; Sonneveld, P; Boccadoro, M; Cook, G; Mateos, MV; Nahi, H; Goldschmidt, H; Dimopoulos, MA; Lucio, P; Blade, J; Delforge, M; Hajek, R; Ludwig, H; Facon, T; San Miguel, JF; Einsele, H;
PUBLISHED: 2019, SOURCE: HAEMATOLOGICA, VOLUME: 104, ISSUE: 12
INDEXED IN: WOS CrossRef: 17
IN MY: ORCID
6
TITLE: Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma
AUTHORS: Mateos, MV; Dimopoulos, MA; Cavo, M; Suzuki, K; Jakubowiak, A; Knop, S; Doyen, C; Lucio, P; Nagy, Z; Kaplan, P; Pour, L; Cook, M; Grosicki, S; Crepaldi, A; Liberati, AM; Campbell, P; Shelekhova, T; Yoon, SS; Iosava, G; Fujisaki, T; Garg, M; Chiu, C; Wang, J; Carson, R; Crist, W; Deraedt, W; Nguyen, H; Qi, M; San Miguel, J; ...More
PUBLISHED: 2018, SOURCE: NEW ENGLAND JOURNAL OF MEDICINE, VOLUME: 378, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 742
IN MY: ORCID
7
TITLE: Gene-gene interaction in ischemic cardiopathy by MDR: beyond logistic regression
AUTHORS: Pereira, A; Palma Dos Reis, RP; Monteiro, J; Sousa, JA; Rodrigues, R; Neto, M; Sousa, AC; Freitas, S; Rodrigues, M; Freitas, AI; Freitas, C; Ornelas, I; Drumond, A; Mendonca, MI;
PUBLISHED: 2018, SOURCE: European-Society-of-Cardiology Congress in EUROPEAN HEART JOURNAL, VOLUME: 39
INDEXED IN: WOS
8
TITLE: Gene - Environment interactions in the cellular axis of ischemic cardiopathy using machine learning models
AUTHORS: Pereira, A; Palma Dos Reis, RP; Rodrigues, R; Monteiro, J; Sousa, JA; Sousa, AC; Henriques, E; Rodrigues, M; Guerra, G; Borges, S; Ornelas, I; Drumond, A; Mendonca, MI;
PUBLISHED: 2018, SOURCE: European-Society-of-Cardiology Congress in EUROPEAN HEART JOURNAL, VOLUME: 39
INDEXED IN: WOS
9
TITLE: Synergistic association between TCF21 gene variant and smoking
AUTHORS: Sousa, JA; Mendonca, MI; Pereira, A; Rodrigues, R; Monteiro, J; Neto, M; Sousa, AC; Henriques, E; Freitas, S; Freitas, AI; Borges, S; Ornelas, I; Drumond, A; Palma Dos Reis, RP;
PUBLISHED: 2018, SOURCE: European-Society-of-Cardiology Congress in EUROPEAN HEART JOURNAL, VOLUME: 39
INDEXED IN: WOS
10
TITLE: Lenalidomide is effective and safe for the treatment of patients with relapsed multiple myeloma and very severe renal impairment  Full Text
AUTHORS: João, C; Freitas, J; Gomes, F; Geraldes, C; Coelho, I; Neves, M; Lúcio, P; Esteves, S; Esteves, GV;
PUBLISHED: 2016, SOURCE: Annals of Hematology, VOLUME: 95, ISSUE: 6
INDEXED IN: Scopus CrossRef
IN MY: ORCID
Page 1 of 4. Total results: 35.